PATENT CLAIM ANALYSIS

Application Number: 15750068
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "230800"]

Abstract:
The present invention relates to liquid formulations of Fosaprepitant intended for parenteral administration. Further the invention also describes process for preparing such formulations.

Claim (Index 4):
A stable, liquid parenteral pharmaceutical formulation of  claim 3  comprising\n (i) Fosaprepitant dimeglumine \n (ii) chelating agents selected from EDTA, DTPA, DOTA and salts thereof \n (iii) one or more stabilizing agents selected from surfactants and cyclodextrins \n (iv) pH adjusting agents and/or buffering agents \n (v) solvents selected from the group comprising of propylene glycol, glycerine, polyethylene glycol and water \n (vi) optionally other pharmaceutically acceptable adjuvants.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 88.0
- Lexical Diversity: 1.19048
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15342445', '15886247', '14242973', '15611785', '12434499']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7445372997648737
- 35 USC 102 Novelty (BERT): 0.4968976159231879
- Combined Prediction Score: 0.7197733313807051
- Mean Citation Score: 202.820424
- Max Citation Score: 253.53969
- Similarity Product: 196.0451182119084

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test